Prevention of Cardiovascular Complications in Diabetic Patients With Vitamin E Treatment


Phase 2/3 Results N/A

Summary of Purpose

The purpose of this study is to determine whether Vitamin E treatment to Diabetic patients, who carry the Haptoglobin 2-2 Phenotype, prevents cardiovascular complications such as acute MI and Stroke. Trial Stopped: interim analysis showed significant differences between two treatment groups

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 February 2007.

1 Apr 2005 13 Sep 2005 Unavailable 1 Dec 2009 1 Feb 2007 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double-Blind
  • Purpose: Prevention
  • Endpoint: Efficacy Study
  • Intervention: Parallel Assignment


Not available